Parietti Véronique, Chifflot Hélène, Muller Sylviane, Monneaux Fanny
CNRS UPR9021 (Immunologie et Chimie Thérapeutiques), 67084 Strasbourg, France.
Ann N Y Acad Sci. 2007 Jun;1108:64-75. doi: 10.1196/annals.1422.007.
Regulatory T cells, especially CD4+CD25+ T cells, "natural killer" T cells and gammadelta T cells, are central in the maintenance of peripheral tolerance and the protection from the development of autoimmune diseases. Numerical or functional modifications of these cell populations were demonstrated to lead to the breakdown of tolerance and the emergence of autoimmunity. Involvement of regulatory T cells in the pathogenesis of systemic autoimmune diseases, such as systemic lupus erythematosus, might be of first importance. In murine models and patients with lupus, these regulatory T cells seem to be reduced in number. Functional deficiencies have also been described in a few studies. A better knowledge of regulatory T cell functional properties in systemic autoimmune diseases is essential to manipulate these cells and hopefully to restore immune tolerance.
调节性T细胞,尤其是CD4+CD25+ T细胞、“自然杀伤”T细胞和γδ T细胞,在维持外周免疫耐受以及预防自身免疫性疾病的发生中起着核心作用。已证实这些细胞群体的数量或功能改变会导致免疫耐受的破坏和自身免疫的出现。调节性T细胞参与系统性自身免疫性疾病(如系统性红斑狼疮)的发病机制可能至关重要。在狼疮的小鼠模型和患者中,这些调节性T细胞的数量似乎减少了。一些研究中也描述了其功能缺陷。更好地了解系统性自身免疫性疾病中调节性T细胞的功能特性对于操控这些细胞并有望恢复免疫耐受至关重要。